Yimi Garcia diagnosed with thoracic outlet syndrome, most likely done for 2026

What happened

Yimi Garcia has been diagnosed with thoracic outlet syndrome, Blue Jays manager John Schneider told Sportsnet's Arden Zwelling and other media, and the right-hander is "most likely" done for the 2026 season. Per Schneider, Garcia has not yet decided whether to undergo surgery for the condition.

The diagnosis follows a July 28 report from Shi Davidi of Sportsnet that the club was sending Garcia for evaluation regarding thoracic outlet syndrome after the reliever had been dealing with neck discomfort during his rehab assignment. At that point, his rehab assignment had already been paused. The evaluation has now returned a result — and it is not a favorable one.

Why it matters

Garcia's situation is less a single piece of bad news than the latest chapter in a prolonged and difficult stretch. It has been more than a year since he last pitched in the big leagues. Per MLB Trade Rumors, an ankle injury early in last season began the cascade. While working back from that ankle issue, he hurt his elbow. A procedure on his arm ended his campaign entirely.

He opened the 2026 season on the 15-day injured list — the standard placement for pitchers under league rules — and was transferred to the 60-day IL at the end of April. A 60-day IL placement removes a player from the 40-man roster count, which is a meaningful administrative signal about the expected length of an absence. Garcia had been working through a rehab assignment when the neck discomfort emerged and prompted the thoracic outlet syndrome evaluation.

Thoracic outlet syndrome is a condition that has ended or significantly disrupted the careers of several pitchers across the sport. The decision on surgery, which Garcia has not yet made per Schneider's remarks, carries real weight: a surgical intervention for TOS typically involves a lengthy recovery, and the "most likely" qualifier Schneider attached to the 2026 prognosis suggests the club is not yet treating the season as formally over — but is clearly preparing for that outcome.

What we don't know yet

The most consequential open question is whether Garcia will elect surgery. Per Schneider's comments to Sportsnet's Zwelling, that decision had not been made as of the manager's remarks. The path forward — and any associated timetable — depends entirely on what Garcia and the club decide together.

It is also worth noting that Schneider's language was "most likely" won't pitch in 2026, not a definitive ruling. That phrasing preserves a narrow possibility, however remote it may appear given the diagnosis and the calendar. No formal club announcement has been made beyond the manager's media availability comments, and MLB Trade Rumors is reporting this as a diagnosis relayed through Schneider, not as a formal transaction or roster move.

Where the club stands

Toronto enters Saturday sitting at 79-83, fifth in the AL East and 19 games back in the division. The Blue Jays have also been eliminated from the Wild Card race, sitting sixth in the Wild Card standings at 5.0 relative to the cut line. They arrive at this Garcia news on a one-game winning streak, for whatever modest comfort that provides.

The schedule ahead offers no particular relief from scrutiny. Saturday and Sunday bring a two-game set at Citizens Bank Park against the Philadelphia Phillies, with Max Scherzer opposing Aaron Nola on Saturday and Shane Bieber facing Jesús Luzardo on Sunday. The club then returns to Rogers Centre on Monday to host the Boston Red Sox, where Jameson Taillon is the probable starter against Sonny Gray.

For a team already eliminated from both the division and Wild Card races, the Garcia news lands differently than it might in a pennant chase. The bullpen implications are real — a reliever who was expected to contribute is now almost certainly unavailable for the remainder of the year — but the larger question is what the diagnosis means for Garcia's availability heading into the offseason and beyond.

Is Garcia on the active roster?

No. Garcia has been on the 60-day injured list since the end of April, per MLB Trade Rumors, which means he was already outside the active roster picture and removed from the 40-man roster count. His rehab assignment, which had been paused when the neck discomfort emerged, is now effectively in suspension pending the outcome of the surgery decision. Under general league rules, a pitcher on a rehab assignment has up to 30 days before he must be activated or moved; that clock is moot until the medical situation resolves.

The 60-day IL placement had already signaled that the club did not expect a quick return. The TOS diagnosis, and Schneider's "most likely" done for 2026 framing, suggests the original pessimism was warranted — and then some.

What to watch

The primary thing to monitor is Garcia's decision on surgery. If he elects a surgical procedure, any timetable for return would extend well beyond 2026, and the club would need to plan accordingly for roster construction heading into the offseason. If he opts against surgery, the "most likely" qualifier in Schneider's remarks leaves a theoretical door open, though the calendar is working against any 2026 return regardless.

Schneider's willingness to address the situation publicly through Sportsnet's Zwelling and other media suggests the club is not trying to manage expectations quietly. That transparency, while appreciated, also underscores how seriously the organization is treating the diagnosis. A reliever who has not appeared in the major leagues in more than a year, who has navigated an ankle injury, an elbow procedure, and now a thoracic outlet syndrome diagnosis, is facing a genuinely uncertain road — and the Blue Jays, already playing out the string at 79-83, are watching that road alongside him.